EN PL
 
EN PL
Bieżący numer
Archiwum
Online first
O czasopiśmie
Dla autorów
Książki i Konferencje
6/2018 vol. 56
Pobierz cytowanie
PRACA PRZEGLĄDOWA
Łuszczyca w szczególnych lokalizacjach.
Klaudia Dopytalska
,
 
Piotr Sobolewski
,
 
Agata Błaszczak
,
 
Elżbieta Szymańska
,
 
Irena Walecka
 
 
 
Więcej
Ukryj
 
Data nadesłania: 04-11-2018
 
 
Data ostatniej rewizji: 03-12-2018
 
 
Data akceptacji: 05-12-2018
 
 
Data publikacji online: 23-12-2018
 
 
Data publikacji: 23-12-2018
 
 
Reumatologia 2018;56(6):392-398
DOI: https://doi.org/10.5114/reum.2018.80718
 
 
Artykuł (PDF)
Referencje (44)
 
SŁOWA KLUCZOWE
facial psoriasis
genital psoriasis
palmoplantar psoriasis
scalp psoriasis
special localization
 
DZIEDZINY
Spondyloartropatie - etiologia, patogeneza, obraz kliniczny i leczenie
 
STRESZCZENIE
Psoriasis is a chronic inflammatory dermatosis affecting 1–3% of the general population. Patients with psoriasis represent a heterogeneous population with individual disease expression – different degrees and severity of skin involvement. Psoriatic lesions in particular localizations such as the face, scalp, intertriginous or palmoplantar areas significantly reduce quality of life. Patients often feel ashamed, embarrassed, or self-conscious about their symptoms. Furthermore, genital psoriasis significantly affects sexual health. Among patients with psoriasis, the prevalence of special localizations is estimated to be 23–27% on the nails, 49% on the face, 12–16% on the palms and soles, and up to 36% in intertriginous regions. Due to peculiar features of skin in these areas, adequate and specific management is required, which is discussed in this review.
 
REFERENCJE (44)
1.
Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 205-212.
Google Scholar
 
 
2.
Reich A, Adamski Z, Chodorowska G, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part I: Mild psoriasis. Dermatol Rev/Przegl Dermatol 2018; 105: 225-243.
Google Scholar
 
 
3.
Merola JF, Li T, Li W, et al. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol 2016; 41: 486-489.
Google Scholar
 
 
4.
Aldredge LM, Higham RC. Manifestations and Management of Difficult-to-Treat Psoriasis. JDNA 2018; 10: 189-197.
Google Scholar
 
 
5.
Frez ML, Asawanonda P, Gunasekara C, et al. Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: A consensus statement from the Asia Scalp Psoriasis Study Group. J Dermatolog Treat 2014; 25: 38-45.
Google Scholar
 
 
6.
Sampogna F, Linder D, Piaserico S, et al. Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Acta Derm Venereol 2014; 94: 411-414.
Google Scholar
 
 
7.
Alpsoy E, Polat M, Fettahlio Glu-Karaman B, et al. Internalized stigma in psoriasis: A multicenter study. J Dermatol 2017; 44: 885-891.
Google Scholar
 
 
8.
Woo SM, Choi JW, Yoon HS, et al. Classification of facial psoriasis based on the distributions of facial lesions. J Am Acad Dermatol 2008; 58: 959-963.
Google Scholar
 
 
9.
Canpolat F, Cemil BC, Eskioglu F, Akis HK. Is facial involvement a sign of severe psoriasis? Eur J Dermatol 2008; 18: 169-171.
Google Scholar
 
 
10.
Van de Kerkhof PCM, Murphy GM, Austad J, et al. Psoriasis of the face and flexures. J Dermatolog Treat 2007; 18: 351-360.
Google Scholar
 
 
11.
Omland SH, Gniadecki R. Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris? Clin Dermatol 2015; 33: 456-461.
Google Scholar
 
 
12.
Fan X, Yang S, Sun LD, et al. Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm Venereol 2007; 87: 335-340.
Google Scholar
 
 
13.
Wang G, Li C, Gao T, et al. Clinical analysis of 48 cases of inverse psoriasis: A hospital-based study. Eur J Dermatol 2005; 15: 176-178.
Google Scholar
 
 
14.
Dubertret L, Mrowietz U, Ranki A, et al. European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736.
Google Scholar
 
 
15.
Fouere S, Adjadj L, Pawin H. How patients experience psoriasis: Results from a European survey. J Eur Acad Dermatol Venereol 2005; 3 (Suppl 19): 2-6.
Google Scholar
 
 
16.
Meeuwis KA, van de Kerkhof PC, Massuger LF, et al. Patients’ experience of psoriasis in the genital area. Dermatology 2012; 224: 271-276.
Google Scholar
 
 
17.
Wozel G. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas. Clin Dermatol 2008; 26: 448-459.
Google Scholar
 
 
18.
Khosravi H, Siegel MP, Van Voorhees AS, Merola JF. Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation.
Google Scholar
 
 
19.
J Drugs Dermatol 2017; 16: 760-766.
Google Scholar
 
 
20.
Sarma N. Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis. Indian J Dermatol 2017; 62: 113-122.
Google Scholar
 
 
21.
Kreuter A, Sommer A, Huyn J, et al. 1% Pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis. Arch Dermatol 2006; 142: 1138-1143.
Google Scholar
 
 
22.
Dubweb GA, Eldebani S, Alhaddar J. Calcipotriol cream in the treatment of flexural psoriasis. Int J Tissue React 2003; 4: 127-130.
Google Scholar
 
 
23.
Lebwohl M, Freeman AK, Chapman MS, et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004; 51: 723-730.
Google Scholar
 
 
24.
Merola JF, Qureshi A, Husni ME. Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatol Ther 2018; 31: e12589.
Google Scholar
 
 
25.
Beck KM, Yang EJ, Sanchez IM, Liao W. Treatment of Genital Psoriasis: A Systematic Review. Dermatol Ther (Heidelb) 2018; 8: 509-525.
Google Scholar
 
 
26.
Meeuwis KAP, Potts Bleakman A, van de Kerkhof PCM, et al. Prevalence of genital psoriasis in patients with psoriasis. J Dermatolog Treat 2018; 29: 754-760.
Google Scholar
 
 
27.
Meeuwis KA, de Hullu JA, Massuger LF, et al. Genital psoriasis: a systematic literature review on this hidden skin disease. Acta Derm Venereol 2011; 91: 5-11.
Google Scholar
 
 
28.
Yang EJ, Beck KM, Sanchez IM, et al. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis (Auckl) 2018; 8: 41-47.
Google Scholar
 
 
29.
Cather JC, Ryan C, Meeuwis K, et al. Patients’ perspectives on the impact of genital psoriasis: a qualitative study. Dermatol Ther 2017; 7: 447-461.
Google Scholar
 
 
30.
Ryan C, Sadlier M, de Vol E, et al. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J Am Acad Dermatol 2015; 72: 978-983.
Google Scholar
 
 
31.
Welsh BM, Berzins KN, Cook KA, et al. Management of common vulval conditions. Med J Aust 2003; 178: 391-395.
Google Scholar
 
 
32.
Albert S, Neill S, Derrick EK, et al. Psoriasis associated with vulval scarring. Clin Exp Dermatol 2004; 29: 354-356.
Google Scholar
 
 
33.
Ryan C, Menter A, Guenther L, et al. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis. Br J Dermatol 2018; 179: 844-852.
Google Scholar
 
 
34.
Kragballe K. Management of Difficult to Treat Locations of Psoriasis Scalp, Face, Flexures, Palm/Soles and Nails. Curr Probl Dermatol 2009; 38: 160-171.
Google Scholar
 
 
35.
Sanchez IM, Sorenson E, Levin E, Liao W. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review. Dermatol Ther (Heidelb) 2017; 7: 425-446.
Google Scholar
 
 
36.
Poulin Y, Crowley JJ, Langley RG, et al. Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH. J Eur Acad Dermatol Venereol 2013; 28: 882-890.
Google Scholar
 
 
37.
Carrascosa JM, Plana A, Ferrándiz C. Effectiveness and safety of psoralen-UVA (PUVA) topical therapy in palmoplantar psoriasis: a report on 48 patients. Actas Dermosifiliogr 2013; 104: 418-425.
Google Scholar
 
 
38.
Chen X, Yang M, Cheng Y, et al. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. Cochrane Database Syst Rev 2013; (10): CD009481.
Google Scholar
 
 
39.
Goldberg DJ, Chwalek J, Hussain M. 308-nm Excimer laser treatment of palmoplantar psoriasis. J Cosmet Laser Ther 2011; 13: 47-49.
Google Scholar
 
 
40.
Bissonnette R, Pariser DM, Wasel NR, et al. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis. J Am Acad Dermatol 2016; 75: 99-105.
Google Scholar
 
 
41.
Janagond AB, Kanwar AJ, Handa S. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study. J Eur Acad Dermatol Venereol 2013; 27: e384-389.
Google Scholar
 
 
42.
Bissonnette R, Poulin Y, Guenther L, et al. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study. J Eur Acad Dermatol Venereol 2011; 25: 1402-1408.
Google Scholar
 
 
43.
Busse K, Liao W. Which Psoriasis Patients Develop Psoriatic Arthritis? Psoriasis Forum 2010; 16: 17-25.
Google Scholar
 
 
44.
Patrizi A, Venturi M, Scorzoni R, et al. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? G Ital Dermatol Venereol 2014; 149: 177-184.
Google Scholar
 
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
Wyślij mailem
Indeksy
 
Indeks słów kluczowych
Indeks dziedzin
Indeks autorów
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
© 2006-2024 Journal hosting platform by Bentus
Scroll to top